Obeticholic acid as second-line therapy for primary biliary cholangitis: Does target trial emulation solve the issue? Bittermann T, Schaubel DE. Hepatology 2024 Dec 20. doi: 10.1097/HEP.0000000000001198.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bittermann T, Schaubel DE. Obeticholic acid as second-line therapy for primary biliary cholangitis: Does target trial emulation solve the issue? Hepatology 2024 Dec 20. doi: 10.1097/HEP.0000000000001198.
PMID: 39705299